title: [Participation in the international multi-countries study-operational issues from company view point].
abstract: AstraZeneca KK has participated in 6 international clinical studies in the development of anticancer agents. Having learned from the experiences, we would like to present operational issues of conducting the international studies in the development of anticancer agents from the standpoint of a pharmaceutical company. Also,we would like to show you differences in Japan from Western and other Asian countries, some aspects that we have to improve or make more efforts, and proposals for the future development to provide patients with good products simultaneously worldwide.
authors.affiliation: AstraZeneca KK, Research and Development, Clinical Division, Clinical Leaders Department Group 1.
authors.forename: Shuji
authors.initials: S
authors.lastname: Hada
mesh_terms: D000970:Antineoplastic Agents; D001208:Asia; D002986:Clinical Trials as Topic / Q000592:standards / Q000639:trends; D004345:Drug Industry / Q000458:organization & administration* / Q000639:trends; D006801:Humans; D007390:International Agencies; D007564:Japan
chemical_list: D000970:Antineoplastic Agents